# EDGAR Filing Document

**Accession Number:** 0001087294
**File Stem:** 0001209191-23-020080
**Filing Date:** 2023-3
**Character Count:** 5988
**Document Hash:** 15665207d4293b00215d47e73b8cd3b3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001209191-23-020080.hdr.sgml**: 20230320

**ACCESSION NUMBER**: 0001209191-23-020080

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230308

**FILED AS OF DATE**: 20230320

**DATE AS OF CHANGE**: 20230320

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Anthony Todd M.
- **CENTRAL INDEX KEY:** 0001969711

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33637
- **FILM NUMBER:** 23747201

**MAIL ADDRESS:**
- **STREET 1:** 1600 WEST END AVENUE
- **STREET 2:** SUITE 1300
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CUMBERLAND PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0001087294
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2525 WEST END AVENUE
- **STREET 2:** SUITE 950
- **CITY:** NASHVILLE,
- **STATE:** TN
- **ZIP:** 37203
- **BUSINESS PHONE:** 615-255-0068

**MAIL ADDRESS:**
- **STREET 1:** 2525 WEST END AVENUE
- **STREET 2:** SUITE 950
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents, I hereby appoint John M. Hamm to act as my agent and
attorney-in-fact for the purpose of completing, executing and filing on my
behalf with the Securities and Exchange Commission, the NASDAQ Stock Market LLC
or any other exchange or self-regulatory body, any Form 3 "Initial Statement of
Beneficial Ownership of Securities", Form 4 "Statement of Changes in Beneficial
Ownership of Securities", Form 5 "Annual Statement of Beneficial Ownership of
Securities", Form 144 "Notice of Proposed Sale of Securities", Schedule 13D
pursuant to Rule 13d-101 of the Securities Exchange Act of 1934, or any other
similar form to report securities ownership that may, in the opinion of any of
them be necessary, with respect to any transaction in securities of Cumberland
Pharmaceuticals Inc.

Nothing herein shall relieve me of the responsibility for the accuracy of the
information and representations contained in any Form 3, Form 4, Form 5, Form
144, Schedule 13D, or other similar form completed, executed and filed pursuant
to this power of attorney.

This power of attorney shall supersede all similar prior powers of attorney and
will remain effective as to the agents and attorneys-in-fact referred to above
until I revoke or amend it by written notice to such persons or until the
undersigned is no longer required to file Form 3, Form 4, Form 5, Form 144,
Schedule 13D or other similar form completed, executed and filed pursuant to
this power of attorney.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed on this 20th day of March 2023.

/s/ Todd M. Anthony

Todd M. Anthony

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Anthony Todd M.<br><sub>(Last) (First) (Middle)</sub><br>1600 WEST END AVE.<br>SUITE 1300<br><sub>(Street)</sub><br>NASHVILLE, TN 37203<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>CUMBERLAND PHARMACEUTICALS INC [ CPIX ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-03-08 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Vice Pres Organizational Dev_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 17144 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Options (right to buy) | 2025-03-17 | 2031-03-17 | Common Stock | 3000 | $3.22 | D |  |
| Options (right to buy) | 2026-03-16 | 2032-03-16 | Common Stock | 6000 | $2.59 | D |  |

---

**Signature:** Todd M. Anthony by /s/ John M. Hamm as attorney-in-fact  
**Date:** 2023-03-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**